Arcosa director granted 1,087 ACA shares

DEMETRIOU STEVEN J. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

DEMETRIOU STEVEN J. reported acquisition or exercise transactions in this Form 4 filing.

Arcosa, Inc. director Steven J. Demetriou received a grant of 1,087 shares of Arcosa common stock on May 13, 2026. The award carried a price of $0.00 per share, indicating it was compensation rather than an open-market purchase. Following this grant, Demetriou directly holds 12,611 shares of Arcosa common stock. This filing records a routine equity-based compensation award to a board member, not a market transaction.

Insider Trade Summary

Grant/Award: 1,087 shares

Grant/Award 1 txn

Insider DEMETRIOU STEVEN J.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,087	$0.00	$0.00

Holdings After Transaction: Common Stock — 12,611 shares (Direct)

Key Figures

Shares granted: 1,087 shares Grant price: $0.00 per share Shares owned after: 12,611 shares +1 more

4 metrics

Shares granted 1,087 shares Common Stock grant on May 13, 2026

Grant price $0.00 per share Equity compensation award, not market purchase

Shares owned after 12,611 shares Direct ownership following the transaction

Transaction code A Grant, award, or other acquisition of Common Stock

Key Terms

Common Stock, Grant, award, or other acquisition, Form 4

3 terms

Common Stock financial

"received a grant of 1,087 shares of Arcosa common stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"coded as a grant, award, or other acquisition at $0.00 per share"

Form 4 regulatory

"reported in this Form 4 as his direct ownership"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Arcosa (ACA) director Steven J. Demetriou report in this Form 4?

Steven J. Demetriou reported receiving a grant of 1,087 Arcosa common shares. The award was priced at $0.00 per share, indicating stock-based compensation, and it increased his direct holdings to 12,611 shares after the transaction.

Was the Arcosa (ACA) Form 4 transaction an open-market buy or sell?

The transaction was not an open-market buy or sell. It is coded as a grant, award, or other acquisition at $0.00 per share, reflecting an equity compensation award rather than a discretionary purchase or sale in the market.

How many Arcosa (ACA) shares does Steven J. Demetriou hold after this grant?

After receiving the 1,087-share grant, Steven J. Demetriou directly holds 12,611 Arcosa common shares. This total is reported in the Form 4 as his direct ownership following completion of the compensation-related transaction.

What is the significance of the $0.00 price in the Arcosa (ACA) Form 4?

The $0.00 price per share indicates the shares were granted as compensation, not purchased. Such awards are typically part of director or executive pay, so this transaction does not represent a cash investment or sale decision in Arcosa stock.

Does this Arcosa (ACA) insider transaction indicate a change in trading sentiment?

This filing reflects a routine stock grant to a director and does not show any open-market buying or selling. Because it is compensation-related, it offers limited insight into the insider’s trading sentiment or view of Arcosa’s share price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/14/2026 - 05:27 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DEMETRIOU STEVEN J.

(Last) (First) (Middle)

500 N. AKARD ST., SUITE 400

(Street)

DALLAS TEXAS 75201

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Arcosa, Inc. [ ACA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/13/2026		A		1,087	A	$0	12,611	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	Mark J. Elmore, by Power of Attorney	05/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)